These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22852065)

  • 21. Characterization of shiga toxin-producing Escherichia coli strains isolated from calves in Poland.
    Osek J; Gallien P; Protz D
    Comp Immunol Microbiol Infect Dis; 2000 Oct; 23(4):267-76. PubMed ID: 11038128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk.
    He X; McMahon S; Skinner C; Merrill P; Scotcher MC; Stanker LH
    J Immunol Methods; 2013 Mar; 389(1-2):18-28. PubMed ID: 23279946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
    MacLeod DL; Gyles CL
    Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shiga toxin subtypes display dramatic differences in potency.
    Fuller CA; Pellino CA; Flagler MJ; Strasser JE; Weiss AA
    Infect Immun; 2011 Mar; 79(3):1329-37. PubMed ID: 21199911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycolipid binding preferences of Shiga toxin variants.
    Karve SS; Weiss AA
    PLoS One; 2014; 9(7):e101173. PubMed ID: 24983355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virulence genes, Shiga toxin subtypes, major O-serogroups, and phylogenetic background of Shiga toxin-producing Escherichia coli strains isolated from cattle in Iran.
    Jajarmi M; Imani Fooladi AA; Badouei MA; Ahmadi A
    Microb Pathog; 2017 Aug; 109():274-279. PubMed ID: 28578089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
    Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
    Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.
    Russo LM; Melton-Celsa AR; Smith MJ; O'Brien AD
    PLoS One; 2014; 9(3):e93463. PubMed ID: 24671194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shiga Toxin Subtypes and Virulence Genes in Escherichia coli Isolated from Cattle.
    Akiyama Y; Futai H; Saito E; Ogita K; Sakae H; Fukunaga M; Tsuji H; Chikahira M; Iguchi A
    Jpn J Infect Dis; 2017 Mar; 70(2):181-185. PubMed ID: 27580573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland.
    Nüesch-Inderbinen M; Morach M; Cernela N; Althaus D; Jost M; Mäusezahl M; Bloomberg G; Stephan R
    Int J Med Microbiol; 2018 Oct; 308(7):933-939. PubMed ID: 30042042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shiga toxin 2 subtypes of enterohemorrhagic E. coli O157:H- E32511 analyzed by RT-qPCR and top-down proteomics using MALDI-TOF-TOF-MS.
    Fagerquist CK; Zaragoza WJ
    J Am Soc Mass Spectrom; 2015 May; 26(5):788-99. PubMed ID: 25667061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Stx2e Monoclonal Antibodies for Immunological Detection and Distinction of Stx2 Subtypes.
    Skinner C; Patfield S; Hernlem BJ; He X
    PLoS One; 2015; 10(7):e0132419. PubMed ID: 26192407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subtyping of Shiga toxin 2 variants in human-derived Shiga toxin-producing Escherichia coli strains isolated in Japan.
    Nakao H; Kimura K; Murakami H; Maruyama T; Takeda T
    FEMS Immunol Med Microbiol; 2002 Dec; 34(4):289-97. PubMed ID: 12443829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants.
    Yosief HO; Iyer SS; Weiss AA
    Infect Immun; 2013 Aug; 81(8):2753-60. PubMed ID: 23690406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable stx
    Burgán J; Krüger A; Lucchesi PMA
    Zoonoses Public Health; 2020 Feb; 67(1):44-53. PubMed ID: 31868306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between stx genotype and Stx2 expression level in Shiga toxin-producing Escherichia coli O157 strains.
    Kawano K; Ono H; Iwashita O; Kurogi M; Haga T; Maeda K; Goto Y
    Jpn J Infect Dis; 2012 Jul; 65(4):322-5. PubMed ID: 22814156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
    Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
    J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin-producing Escherichia coli strains by a time-resolved fluorescence immunoassay.
    Wen T; Huang C; Zhang Y; Zeng X; Liu W; Jiao Z; Guo X; Jiao Y
    Luminescence; 2018 May; 33(3):574-581. PubMed ID: 29350441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15.
    Kimura T; Tani S; Motoki M; Matsumoto Y
    Biochem Biophys Res Commun; 2003 Jun; 305(4):1057-60. PubMed ID: 12767937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxigenic properties and stx phage characterization of Escherichia coli O157 isolated from animal sources in a developing country setting.
    Rahman M; Nabi A; Asadulghani M; Faruque SM; Islam MA
    BMC Microbiol; 2018 Aug; 18(1):98. PubMed ID: 30170562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.